News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RheoGene, Inc. Introduces AttSite(TM) Recombinases



10/19/2005 5:10:20 PM

NORRISTOWN, PA -- (MARKET WIRE) -- 05/10/2005 -- RheoGene Inc., a biotechnology developer of products and technologies that regulate gene expression, announces the introduction of AttSite Recombinases, novel gene-targeting enzymes that direct site-specific DNA modification in a wide range of organisms. Each enzyme catalyzes the irreversible integration or excision of DNA sequences at specific locations within the genome, with broad applications in functional genomics, transgenics technology, biotherapeutic protein production and stem cell and gene therapy.

Read at Market Wired


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES